⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
FATE News
Fate Therapeutics, Inc.
Fate Therapeutics Presents Updated Preliminary Data for FT819 in Active Lupus Nephritis at American Society of Nephrology Kidney Week 2026
globenewswire.com
FATE
Engineered T Cells Market - Global Forecast 2026-2032 | CAR-T, TCR-T, and Allogeneic Platforms Unlock 8.06% CAGR and a USD 41.99 Billion Opportunity
globenewswire.com
ALLO
AMGN
ATRA
AUTL
BB
BMY
CRSP
FATE
GILD
IMCR
REGN
PFE
SANG
TCRT
Respiratory Infection Diagnostics Market Forecast 2025-2029 by Technology, Plex, Testing Site, Product, and Region | Multiplex and Point-of-Care Testing Unlock New Growth
globenewswire.com
QGEN
CODX
BDX
BIOX
TKO
GTEC
CUE
BFC
HOG
FGEN
ABT
DXCM
TMO
DHR
QDEL
LH
DGX
SYK
ALGN
EXAS
ILMN
GOOG
MSFT
AMZN
NVDA
INTC
AMD
CRM
IBM
ORCL
CSCO
NFLX
CMCSA
PEP
KO
MCD
DIS
BA
CAT
GE
XOM
CVX
PFE
MRK
JNJ
BMY
GILD
AMGN
REGN
VRTX
BIIB
AZN
SNY
NVS
TEVA
BABA
JD
BIDU
NTES
PDD
SIRI
EA
TTWO
ADPT
ALNY
ASMB
AXNX
BCRX
BEAM
CDXS
CGEN
CHKP
CLDX
CRIS
CTAS
CYTK
DAVA
DECK
DTIL
EDIT
ENTX
EVTC
EXEL
FATE
FCEL
FLEX
FORM
FTNT
FTV
GALT
GEN
GNTX
GRMN
GSK
HALO
HAYW
HBIO
HIMX
HOLX
HTHT
IDXX
INCY
INSM
INTU
IOVA
ISRG
JAZZ
KDP
KHC
KLAC
KODK
LAKE
LCID
LRCX
LSCC
LULU
LYFT
MCHP
MDLZ
MELI
MGM
MNST
MRVL
MU
NCLH
NDSN
NEO
NET
NI
NKE
NOC
NOV
NTAP
NXPI
OMC
ON
ORLY
OSK
OTIS
PACB
PAYX
PCAR
PCG
PENN
PERI
PETS
PGR
PHG
PI
PINS
PLAB
PLUG
PM
PNW
POOL
POST
PPG
PRGS
PRTA
PSX
PTC
PTON
PYPL
QCOM
QRVO
RCL
RDNT
REG
RGEN
RIVN
RL
ROST
RS
RVSN
RYAAY
S
SAN
SBAC
SBUX
SCHW
SE
SEDG
SEIC
SITE
SLAB
SLM
SMCI
SNA
SNOW
SNPS
SOFI
SPNS
SRPT
SSNC
STAG
STX
SWKS
T
TAL
TCOM
TDOC
TEAM
TECK
TER
TFX
TGT
TGS
TIGR
TLRY
TM
TMHC
TNDM
TNK
TOL
TOP
TOST
TPL
TRMB
TRMK
TRP
TSLA
TSN
TTD
TTC
TXN
TXRH
TYL
U
UAL
ULTA
UMC
UNH
UNP
UPS
URBN
V
VRSK
VRSN
VTR
VTRS
WDC
WEC
WEN
WFC
WGO
WHR
WMB
WMT
WST
WU
WYNN
XBIT
XCUR
XENE
XPO
XRAY
XYL
YETI
YUM
ZBRA
ZIM
ZION
ZTS
Fate Therapeutics Appoints Jamie Harrell as Senior Vice President, Market Development & Commercial Operations to Lead the Commercialization of CAR T-cell Therapies
globenewswire.com
FATE
Form 8-K
sec.gov
ENTX
GILD
AMGN
JAZZ
FATE
MRK
OPK
Entera Appoints Global BioPharma Executive Laura Hamill to Its Board of Directors, Expanding Commercial Expertise
globenewswire.com
ENTX
JAZZ
FATE
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
FATE
Fate Therapeutics to Participate in Upcoming Fourth Quarter 2026 Conferences
globenewswire.com
FATE
Form 8-K
sec.gov
FATE
Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN
globenewswire.com
FATE